The global botulinum toxin injection market is anticipated to grow at a significant CAGR of 5.9% during the forecast period (2022-2028). Botulinum toxin is a drug made from a toxin that is produced by the bacterium clostridium botulinum and is used in small doses for the treatment of health problems such as temporary smoothing of facial wrinkles and improving appearance. The surge in the demand for facial aesthetics is anticipated as one of the factors which is driving the growth of the botulinum toxin injection market. Moreover, botulinum toxin is used to treat several age-related conditions such as forehead lines, glabellar lines and others. Hence, people above the age of 40 are expected to be prone to such signs of ageing. This botulinum toxin procedure is expected to gain more importance among the population aged between 40 -54 years, thereby augmenting the market growth.
To Request a Sample of our Report on Global Botulinum Toxin Injection Market: https://www.omrglobal.com/request-sample/botulinum-toxin-injection-market
Globally, the spread of the COVID-19 pandemic impacted the botulinum toxin injection market negatively in 2020. Various companies witnessed a decline from 9% to 30% in the sales of botulinum toxin products due to COVID-19. For instance, Allergan, a key player among the botox market reported the decline of 33.1% to 34.8% of revenue in 2020. In addition, imposition of lockdown and various restrictions at national level postponed the non-essential surgical and non-invasive procedures. According to the American Society of Plastic Surgeons (ASPS) reports, in 2020, the total number of Botox type A procedures declined from 5.04 million in 2019 to 4.40 million. Additionally, the market observed a decline of 12.7% in botox procedures across the globe.
A full Report of Global Botulinum Toxin Injection Market is Available @ https://www.omrglobal.com/industry-reports/botulinum-toxin-injection-market
Global Botulinum Toxin Injection Market Segmentation
By Application
- Therapeutics
- Chronic Migraine
- Spasticity
- Overactive Bladder
- Cervical Dystonia
- Blepharospasm
- Aesthetics
By Type
- Botulinum Toxin Type A
- Botulinum Toxin Type B
By End User
- Hospital and clinics
- Specialty and Dermatology Clinic
- Others
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Abbott Laboratories
- Abaxis
- AjinoMoto Bio Pharma Services
- Alembic Pharmaceuticals Ltd.
- Amgen, Inc.
- AstraZeneca PLC
- Bristol Myers Squibb
- Biogen Inc.
- Bausch + Lomb
- Celgene Corp.
- C’Bon Cosmetics Co. Ltd.
- EMS
- Eli Lilly and Co.
- Gilead Sciences, Inc.
- Merz Pharma GmbH & Co. KGaA
- Revance
- Hoffmann-La Roche AG
- Takeda Pharma Co.
- Sanofi SA
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/botulinum-toxin-injection-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
